All
Research
Education
Ricerca
Didattica
Business
Soluzioni
IT
EN - English
CN - 中文
DE - Deutsch
ES - Español
KR - 한국어
IT - Italiano
FR - Français
PT - Português
TR - Türkçe
JA - 日本語
PL - Polski
RU - Русский
HE - עִברִית
AR - العربية
Accedi
Department of Hepatobiliary Surgery
Yinghai Xie has not added Biography.
If you are Yinghai Xie and would like to personalize this page please email our Author Liaison for assistance.
PKI-587 enhances chemosensitivity of oxaliplatin in hepatocellular carcinoma through suppressing DNA damage repair pathway (NHEJ and HR) and PI3K/AKT/mTOR pathway.
American journal of translational research , 2019 | Pubmed ID: 31497229
BEZ235 increases sorafenib inhibition of hepatocellular carcinoma cells by suppressing the PI3K/AKT/mTOR pathway.
American journal of translational research , 2019 | Pubmed ID: 31632530
BEZ235 enhances chemosensitivity of paclitaxel in hepatocellular carcinoma through inhibiting the PI3K/Akt/mTOR pathway.
American journal of translational research , 2019 | Pubmed ID: 31934276
The PI3K/mTOR dual inhibitor BEZ235 nanoparticles improve radiosensitization of hepatoma cells through apoptosis and regulation DNA repair pathway.
Nanoscale research letters Mar, 2020 | Pubmed ID: 32219609
LY3214996 relieves acquired resistance to sorafenib in hepatocellular carcinoma cells.
International journal of medical sciences , 2021 | Pubmed ID: 33628103
BEZ235 Increases the Sensitivity of Hepatocellular Carcinoma to Sorafenib by Inhibiting PI3K/AKT/mTOR and Inducing Autophagy.
BioMed research international , 2021 | Pubmed ID: 33987439
PKI-587 enhances radiosensitization of hepatocellular carcinoma by inhibiting the PI3K/AKT/mTOR pathways and DNA damage repair.
PloS one , 2021 | Pubmed ID: 34665844
Lupeol-Loaded Nanoparticles Enhance the Radiosensitivity of Hepatocellular Carcinoma by Inhibiting the Hyperactivation in Raf/Mitogen-Activated Protein Kinase and Phospatidylinositol-3 Kinase/mTOR Pathways.
Journal of biomedical nanotechnology Nov, 2021 | Pubmed ID: 34906285
Retraction Note: The PI3K/mTOR Dual Inhibitor BEZ235 Nanoparticles Improve Radiosensitization of Hepatoma Cells Through Apoptosis and Regulation DNA Repair Pathway.
Nanoscale research letters Dec, 2021 | Pubmed ID: 34914025
ASIC1a stimulates the resistance of human hepatocellular carcinoma by promoting EMT via the AKT/GSK3β/Snail pathway driven by TGFβ/Smad signals.
Journal of cellular and molecular medicine May, 2022 | Pubmed ID: 35426224
ASIC1α up-regulates MMP-2/9 expression to enhance mobility and proliferation of liver cancer cells via the PI3K/AKT/mTOR pathway.
BMC cancer Jul, 2022 | Pubmed ID: 35840921
The First Affiliated Hospital of Anhui University of Science & Technology
Lei Xu*,1,2,
Manman Xu*,3,
Yinghai Xie4,
Wei You2,
Jianxin Wang2,
Liwu Xu4,
Qizhu Feng4,
Jie Sun4,
Jian Zhang4,
Huaichen Yang4,
Wang Qi4
1, The First Affiliated Hospital of Anhui University of Science & Technology,
2, Medical College of Anhui University of Science & Technology,
3Endocrinology Department, The First Affiliated Hospital of Anhui University of Science & Technology,
4Department of Hepatobiliary Surgery, The First Affiliated Hospital of Anhui University of Science & Technology
Riservatezza
Condizioni di utilizzo
Politiche
Contattaci
SUGGERISCI JOVE ALLA BIBLIOTECA
Newsletter di JoVE
JoVE Journal
Raccolta di metodi
JoVE Encyclopedia of Experiments
Archivio
JoVE Core
JoVE Science Education
JoVE Lab Manual
JoVE Quiz
JoVE Playlist
Autori
Personale delle biblioteche
Accesso
CHI SIAMO
JoVE Sitemap
Copyright © 2025 MyJoVE Corporation. Tutti i diritti riservati
Utilizziamo i cookies per migliorare la tua esperienza sul nostro sito web.
Continuando a utilizzare il nostro sito web o cliccando “Continua”, accetti l'utilizzo dei cookies.
Per saperne di più